INNATE PHARMA SA (IPH.PA) Stock Analyst Ratings
Europe - Euronext Paris - EPA:IPH - FR0010331421 - Common Stock
1.524 EUR
-0.01 (-0.52%)
ChartMill assigns a Buy % Consensus number of 80% to IPH.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.99. This target is 227.73% above the current price.
IPH.PA was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IPH.PA.
In the previous month the buy percentage consensus was at a similar level.
IPH.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
INNATE PHARMA SA / IPH.PA FAQ
Can you provide the average price target for INNATE PHARMA SA stock?
9 analysts have analysed IPH.PA and the average price target is 4.99 EUR. This implies a price increase of 227.73% is expected in the next year compared to the current price of 1.524.
What is the consensus rating for IPH stock?
The consensus rating for INNATE PHARMA SA (IPH.PA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.